Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism

Clinical Microbiology and Infection

Volumn 22, Issue 3, 2016, Pages 277.e1-277.e9

  Prakash, A ^a   Sharma, C ^a   Singh, A ^a   Kumar Singh, P ^a   Kumar, A ^b   Hagen, F ^c   Govender, N P ^d   Colombo, A L ^e   Meis, J F ^c,f   Chowdhary, A ^a  

^a UNIVERSITY OF DELHI   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amplified fragment length polymorphism; Candida auris; D1 D2; Internal transcribed spacer; Matrix assisted laser desorption ionization time of flight mass spectrometry; RPB1; RPB2

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; INTERNAL TRANSCRIBED SPACER; ISAVUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; RIBOSOME DNA; VORICONAZOLE; ANTIFUNGAL AGENT; RIBOSOMAL SPACER DNA;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BRAZIL; BROTH DILUTION; CANDIDA; CANDIDA AURIS; CONTROLLED STUDY; DNA SEQUENCE; FUNGAL GENETICS; FUNGUS ISOLATION; GENE CLUSTER; GENETIC VARIABILITY; GENOTYPE; INDIA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PHYLOGENETIC TREE; POPULATION STRUCTURE; PRIORITY JOURNAL; RPB1 GENE; RPB2 GENE; SOUTH AFRICA; CANDIDIASIS; CLASSIFICATION; DRUG EFFECTS; FUNGAL GENE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYLOGENY;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DNA, RIBOSOMAL SPACER; GENES, FUNGAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PHYLOGENY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84959565821     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.10.022     Document Type: Article

References (28)

1. Satoh K., Makimura K., Hasumi Y., Nishiyama Y., Uchida K., Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 2009, 53:41-44.
2. Chowdhary A., Sharma C., Duggal S., Agarwal K., Prakash A., Singh P.K., et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 2013, 19:1670-1673.
3. Lee W.G., Shin J.H., Uh Y., Kang M.G., Kim S.H., Park K.H., et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 2011, 49:3139-3142.
4. Chowdhary A., Anil Kumar V., Sharma C., Prakash A., Agarwal K., Babu R., et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 2014, 33:919-926.
5. Magobo R.E., Corcoran C., Seetharam S., Govender N.P. Candida auris-associated candidemia, South Africa. Emerg Infect Dis 2014, 20:1250-1251.
6. Emara M., Ahmad S., Khan Z., Joseph L., Al-Obaid I., Purohit P., et al. Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis 2015, 21:1091-1092.
7. Kathuria S., Singh P.K., Sharma C., Prakash A., Masih A., Kumar A., et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI Broth Microdilution, and Etest method. J Clin Microbiol 2015, 53:1823-1830.
8. Kim M.N., Shin J.H., Sung H., Lee K., Kim E.C., Ryoo N., et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 2009, 48:e57-61.
9. Khillan V., Rathore N., Kathuria S., Chowdhary A. A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease. JMM Case Rep 2014, 10.1099/jmmcr.0.T00018.
10. Cendejas-Bueno E., Kolecka A., Alastruey-Izquierdo A., Theelen B., Groenewald M., Kostrzewa M., et al. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol 2012, 50:3641-3651.
11. Kurtzman C.P., Robnett C.J. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997, 35:1216-1223.
12. White T.J., Bruns T., Lee S., Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols: a guide to methods and applications 1990, 315-322. Academic Press, San Diego, CA. M.A. Innis, D.H. Gelfand, J.J. Sninsky, T.J. White (Eds.).
13. Liu Y.J., Whelen S., Hall B.D. Phylogenetic relationships among ascomycetes: evidence from an RNA polymerase II subunit. Mol Biol Evol 1999, 16:1799-1808.
14. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 2013, 30:2725-2729.
15. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts 2008, approved standard-3rd ed. CLSI document M27-A3, CLSI, Wayne, PA.
16. Pfaller M.A., Boyken L.B., Hollis R.J., Kroeger J., Messer S.A., Tendolkar S., et al. Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program. J Clin Microbiol 2008, 46:3585-3590.
17. Pfaller M.A., Boyken L.B., Hollis R.J., Kroeger J., Messer S.A., Tendolkar S., et al. Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program. J Clin Microbiol 2011, 49:1274-1279.
18. Oh B.J., Shin J.H., Kim M.N., Sung H., Lee K., Joo M.Y., et al. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol 2011, 49:98-102.
19. Blignaut E., Pujol C., Lockhart S., Joly S., Soll D.R. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa. J Clin Microbiol 2002, 40:826-836.
20. Pujol C., Pfaller M., Soll D.R. Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade. J Clin Microbiol 2002, 40:2729-2740.
21. Dodgson A.R., Pujol C., Denning D.W., Soll D.R., Fox A.J. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol 2003, 41:5709-5717.
22. Odds F.C., Bougnoux M.E., Shaw D.J., Bain J.M., Davidson A.D., Diogo D., et al. Molecular phylogenetics of Candida albicans. Eukaryot Cell 2007, 6:1041-1052.
23. Dhieb C., Normand A.C., Al-Yasiri M., Chaker E., El Euch D., Vranckx K., et al. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata. Med Mycol 2015, 53:462-469.
24. De Carolis E., Hensgens L.A., Vella A., Posteraro B., Sanguinetti M., Senesi S., et al. Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP. Med Mycol 2014, 52:123-130.
25. Kathuria S., Sharma C., Singh P.K., Agarwal P., Agarwal K., Hagen F., et al. Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing. PLoS One 2015, 10:e0118997.
26. Sharma C., Kumar N., Meis J.F., Pandey R., Chowdhary A. Draft genome sequence of fluconazole-resistant Candida auris strain from candidemia patient in India. Genome Announc 2015, 3:e00722-15.
27. Zautner A.E., Masanta W.O., Weig M., Groß U., Bader O. Mass Spectrometry-based PhyloProteomics (MSPP): a novel microbial typing method. Sci Rep 2015, 5:13431.
28. Wolters M., Rohde H., Maier T., Belmar-Campos C., Franke G., Scherpe S., et al. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages. Int J Med Microbiol 2011, 301:64-68.